Related Experiment Video
Updated: Oct 23, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - Relevance to Age-Related Left
Eisaku Harada1, Yuji Mizuno1, Fumihito Kugimiya1
1Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute.
Insights
Plasma B-type natriuretic peptide (BNP) levels are lower in heart failure with preserved ejection fraction (HFpEF) and linked to aging-related cardiac remodeling. This contrasts with heart failure with reduced ejection fraction (HFrEF), which shows eccentric hypertrophy.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Pathophysiology
Background:
- Heart failure with preserved ejection fraction (HFpEF) is a growing concern, particularly in aging populations.
- Plasma B-type natriuretic peptide (BNP) levels correlate with left ventricular (LV) dysfunction severity.
- Understanding BNP in HFpEF is crucial for elucidating its pathogenesis compared to heart failure with reduced ejection fraction (HFrEF).
Purpose of the Study:
- To investigate plasma B-type natriuretic peptide (BNP) levels in patients with HFpEF.
- To compare BNP levels and associated cardiac characteristics between HFpEF and HFrEF.
- To explore the relationship between BNP and LV remodeling in HFpEF.
Main Methods:
- A cohort of 468 HFpEF patients and 126 HFrEF patients underwent echocardiography and clinical assessments, including plasma BNP measurement.
- Demographic and clinical data, including age, sex, blood pressure, and LV parameters (diastolic dimensions, mass index, relative wall thickness), were analyzed.
- Multiple regression analysis identified predictors of plasma BNP levels.
Main Results:
- HFpEF patients were older, predominantly female, and had higher systolic and pulse pressures than HFrEF patients.
- Plasma BNP levels, LV diastolic dimensions, and LV mass index (LVMI) were lower in HFpEF, while relative wall thickness was higher.
- LVMI, ejection fraction (EF), albumin, C-reactive protein, and uric acid predicted BNP levels.
Conclusions:
- Plasma BNP levels are lower in HFpEF and associated with aging-related LV concentric remodeling.
- HFpEF differs from HFrEF, where LV hypertrophy is predominantly eccentric.
- These findings highlight distinct pathophysiological mechanisms in HFpEF versus HFrEF.
Background:
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasing with aging of the population. Plasma levels of B-type natriuretic peptide (BNP) increase in proportion to the severity of left ventricular (LV) dysfunction. The object of this study was to examine the plasma levels of BNP in HFpEF to better understand the pathogenesis of HFpEF as compared with HF with reduced EF (HFrEF).
Methods And Results:
The study subjects comprised 468 HFpEF patients (158 men, 310 women, mean age 81.3±9.6 years) and 126 HFrEF patients (77 men, 49 women, mean age 75.4±12.0 years) who underwent echocardiography and routine clinical examinations including plasma BNP. Age, female prevalence, systolic blood pressure and pulse pressure were higher in the HFpEF patients than in the HFrEF patients (P<0.0001, P<0.001, P<0.0001, and P<0.0001, respectively). Plasma BNP levels, LV diastolic dimensions, and LV mass index (LVMI) were lower (P<0.0001, P<0.0001, and P<0.0001, respectively), while relative wall thickness was higher (P<0.0001) in the HFpEF patients than in the HFrEF patients. Multiple regression analysis revealed that LVMI, EF, plasma levels of albumin, C-reactive protein, and uric acid were the predictors of BNP levels (P<0.001, P<0.001, P=0.009, P=0.012, and P=0.018, respectively).
Conclusions:
Plasma BNP levels were lower and related to aging-related LV concentric remodeling/hypertrophy in HFpEF patients as compared with HFrEF patients, who were associated predominantly with eccentric LV hypertrophy.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management

